Filing Details

Accession Number:
0001125345-18-000014
Form Type:
4/A
Zero Holdings:
No
Publication Time:
2018-01-26 16:01:50
Reporting Period:
2018-01-24
Accepted Time:
2018-01-26 16:01:50
Original Submission Date:
2018-01-25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1125345 Macrogenics Inc MGNX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1587774 Blasius Eric Risser 9704 Medical Center Drive
Rockville MD 20850
Sr Vp & Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-01-24 3,000 $0.94 12,100 No 4 M Direct
Common Stock Disposition 2018-01-24 3,000 $22.50 9,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee stock option (right to buy) Disposition 2018-01-24 3,000 $0.00 3,000 $0.94
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
26,497 2009-09-24 2019-03-23 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted 11/14/17.
  2. The Form 4, as originally filed on 1/25/18, incorrectly reported the sale price. The Form 4, as amended by this Form 4/A, correctly reports such information.
  3. The price reported in Column 4 is a weighted average price. This transaction was executed in multiple trades at prices ranging from $22.50 to $22.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.